Envoy Medical, Inc. COCH
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 30.77% | -48.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 30.77% | -48.00% | |||
| Cost of Revenue | -11.18% | 1,390.48% | |||
| Gross Profit | 17.15% | -607.41% | |||
| SG&A Expenses | 8.17% | 20.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.30% | -4.34% | |||
| Operating Income | 6.54% | 3.81% | |||
| Income Before Tax | -37.49% | 33.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -37.49% | 33.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -37.49% | 33.94% | |||
| EBIT | 6.54% | 3.81% | |||
| EBITDA | 6.64% | 3.74% | |||
| EPS Basic | 15.48% | 69.57% | |||
| Normalized Basic EPS | 8.88% | 71.94% | |||
| EPS Diluted | 15.48% | 69.57% | |||
| Normalized Diluted EPS | 8.88% | 71.94% | |||
| Average Basic Shares Outstanding | 50.92% | 142.13% | |||
| Average Diluted Shares Outstanding | 50.92% | 142.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||